Endothelial MICU1 protects against vascular inflammation and atherosclerosis by inhibiting mitochondrial calcium uptake
Journal of Clinical Investigation · 01.04.2025 · 135 (7)
DOI: 10.1172/jci181928 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 01.04.2025. Verfasst von Lu Sun und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of C…. Hauptthemen laut MEDLINE: Calcium, Atherosclerosis, Mitochondria, Calcium-Binding Proteins. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, the Strategic Priority Research Program of the Chinese Academy of Sciences, the Program for Innovative Research Team of The First Affiliated Hospital of USTC.
Abstract (Originalsprache)
Mitochondrial dysfunction fuels vascular inflammation and atherosclerosis. Mitochondrial calcium uptake 1 (MICU1) maintains mitochondrial Ca 2+ homeostasis. However, the role of MICU1 in vascular inflammation and atherosclerosis remains unknown. Here, we report that endothelial MICU1 prevents vascular inflammation and atherosclerosis by maintaining mitochondrial homeostasis. We observed that vascular inflammation was aggravated in endothelial cell–specific Micu1 knockout mice ( Micu1 ECKO ) and attenuated in endothelial cell–specific Micu1 transgenic mice ( Micu1 ECTg ). Furthermore, hypercholesterolemic Micu1 ECKO mice also showed accelerated development of atherosclerosis, while Micu1 ECTg mice were protected against atherosclerosis. Mechanistically, MICU1 depletion increased mitochondrial Ca 2+ influx, thereby decreasing the expression of the mitochondrial deacetylase sirtuin 3 (SIRT3) and the ensuing deacetylation of superoxide dismutase 2 (SOD2), leading to the burst of mitochondrial reactive oxygen species (mROS). Of clinical relevance, we observed decreased MICU1 expression in the endothelial layer covering human atherosclerotic plaques and in human aortic endothelial cells exposed to serum from patients with coronary artery diseases (CAD). Two-sample Wald ratio Mendelian randomization further revealed that increased expression of MICU1 was associated with decreased risk of CAD and coronary artery bypass grafting (CABG). Our findings support MICU1 as an endogenous endothelial resilience factor that protects against vascular inflammation and atherosclerosis by maintaining mitochondrial Ca 2+ homeostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
- Department of Pharmacy, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
- Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, China.
- Department of Biomedical Sciences, City University of Hong Kong, Hong Kong, China.
- School of Basic Medical Sciences, State Key Lab of Respiratory Disease, Guangzhou Medical University, Guangzhou, Guangdong, China.
- Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA.
Förderung
- the National Natural Science Foundation of China
- the Strategic Priority Research Program of the Chinese Academy of Sciences
- the Program for Innovative Research Team of The First Affiliated Hospital of USTC
- Anhui Provincial Key Research and Development Program
- Anhui Provincial Natural Science Foundation
- the National Key R&D Program of China
- Hong Kong Research Grants Council
- the British Heart Foundatio
Zitieren
APA
Sun, L., Leng, R., Liu, M., Su, M., He, Q., Zhang, Z., Liu, Z., Wang, Z., Jiang, H., Wang, L., Guo, S., Xu, Y., Huo, Y., Miller, C. L., Banach, M., Huang, Y., Evans, P. C., Pelisek, J., Camici, G. G., …, & Weng, J. (2025). Endothelial MICU1 protects against vascular inflammation and atherosclerosis by inhibiting mitochondrial calcium uptake. Journal of Clinical Investigation, 135(7). https://doi.org/10.1172/jci181928
Vancouver
Sun L, Leng R, Liu M, Su M, He Q, Zhang Z, et al. Endothelial MICU1 protects against vascular inflammation and atherosclerosis by inhibiting mitochondrial calcium uptake. Journal of Clinical Investigation. 2025;135(7). doi:10.1172/jci181928
BibTeX
@article{Sun2025,
author = {Sun, Lu and Leng, Ruixue and Liu, Monan and Su, Meiming and He, Qingze and Zhang, Zhidan and Liu, Zhenghong and Wang, Zhihua and Jiang, Hui and Wang, Li and Guo, Shuai and Xu, Yiming and Huo, Yuqing and Miller, Clint L and Banach, Maciej and Huang, Yu and Evans, Paul C and Pelisek, Jaroslav and Camici, Giovanni G and Berk, Bradford C and Offermanns, Stefan and Ge, Junbo and Xu, Suowen and Weng, Jianping},
title = {Endothelial MICU1 protects against vascular inflammation and atherosclerosis by inhibiting mitochondrial calcium uptake},
journal = {Journal of Clinical Investigation},
year = {2025},
volume = {135},
number = {7},
doi = {10.1172/jci181928}
}
EUVIMED